Kris Jenner's new face and the rise of the deep plane facelift
This lift restores natural volume to the cheeks, enhances the jawline and can cost up to R275 000.
Local doctors reveal South African cosmetic enhancement trends like fat grafting and platelet-rich plasma therapy.
_______________________________________________________________________
Everyone and their mother is talking about Kris Jenner's new face.
The famed momager to the A-list socialite family created a world of buzz when she stepped out in Paris looking like she'd just drunk from the fountain of youth.
Kris' procedure is believed to be a deep plane facelift. Locally, actor Khanyi Mbau's blepharoplasty also sparked a conversation about a major trend: the rise of natural-looking facelifts that don't scream 'surgery'.
View this post on Instagram
A post shared by Khanyi Mbau Metanoia (@mbaureloaded)
Professor Chrysis Sofianos, one of South Africa's top plastic surgeons and among the few in the country offering this specialised procedure, describes to TRUELOVE the deep plane facelift as 'the gold standard in facial rejuvenation'.
'Unlike traditional facelifts that pull on the skin, this technique repositions the deeper structures beneath the SMAS (superficial musculoaponeurotic system) layer. This vertical lift restores natural volume to the cheeks, enhances jawline definition and rejuvenates the neck – without distorting facial expression or creating a 'tight' look.'
View this post on Instagram
A post shared by Kris Jenner (@krisjenner)
The Kardashian/Jenner clan has been no stranger to cosmetic surgery conversations but it seems as though they're more open and honest about procedures they've done.
People confirmed that Kris underwent cosmetic enhancement from New York City-based plastic surgeon Dr Steven Levine. The youngest of the family, Kylie Jenner, also gave some insight into her breast augmentation surgery, citing Beverley Hills plastic surgeon Dr Garth Fisher as the magician behind her and many of her family's procedures.
This came as a pleasant surprise from the former secretive approach Kylie took to keep her aesthetic enhancements under wraps.
not kylie jenner sharing her breast implant details in tiktok comment 😭 pic.twitter.com/WN0spo3j5z
— 2000s (@PopCulture2000s) June 3, 2025
'Surgery is an art form and any surgery can look real or look false. There are many traditional facelifts and blepharoplasties patients who will look natural or like they have not had any plastic surgery done. What is different is that they are done by talented plastic surgeons,' says Johannesburg-based aesthetic doctor Dr Reza Mia.
Curious about what exactly goes in to getting this groundbreaking facial procedure? The experts have got you covered.
Specifics of the deep plane facelift
From pricing in South Africa to recovery time, Professor Chrysis shares some insight into the specifics of the deep plane facelift.
'In South Africa, a deep plane face and neck lift typically costs between R150 000 and R200 000, depending on surgical complexity and hospital setting. When combined with procedures like eyelid surgery, lip lifts or skin resurfacing, a full facial rejuvenation package can cost up to R275 000.
'Recovery is usually smoother than with older techniques. Initial swelling and bruising resolve within 10 to 14 days, with most patients returning to daily activities in two to three weeks. Full recovery takes a few months, with final results revealing a refreshed and natural appearance,' Professor Chrysis explains.
He also highlights that in the recovery phase after surgery, doctors will put together tailored recovery plans for each patient and do non-surgical treatments like Botox, laser resurfacing and derma fillers to maintain results and enhance the look.
Rising cosmetic surgery trends in South Africa
Many local stars have been vocal about their cosmetic procedures, whether the decision was based on a medical need or purely for confidence.
From Boity Thulo's breast reduction and Lalla Hiryama's implant removal to Sithelo Shozi and Gogo Skhotheni's Brazilian butt lifts (BBLs), local surgeons are seeing a definite rise in natural. subtle body and face rejuvenation procedures.
As a growing number of South Africans view cosmetic procedures as an investment in confidence and wellbeing, some medical institutions are now offering structured payment plans to make surgery more accessible.
Professor Chrysis Sofianos
Professor Chrysis reveals that he is seeing these trends in women in their 30s and 50s hoping to keep a youthful and refreshed appearance without looking overdone.
'The deep plane facelift, fat grafting and regenerative treatments like Morpheus8 and PRP (platelet-rich plasma) therapy are all in high demand among this group. These procedures offer refined, long-lasting results and can be tailored to the individual's anatomy and stage of ageing.'
He continues, 'At the same time, we've seen a steady increase in male patients, particularly professionals in their 40s and 50s, seeking subtle enhancements to reduce signs of stress and fatigue while maintaining a masculine appearance.'
Dr Reza echoes Professor Chrysis' findings and explains why PRP therapy is becoming so popular in Mzansi.
'The most exciting innovation we've seen in recent times is the platelets-rich evolution of platelets. It gives us an ability to give patience the universally attractive traits of healthy skin and a full head of hair at the same time we're able to make filler out of the actual blood.
'The patients don't need to rely on artificial hyaluronic acid fillers and its unfortunate side effects and we're able to then make great results, which are also stimulating the skin. It also it gives us something that could never be done before. We are able to inject into the breasts to make them bigger and more voluptuous all with the patient's own blood.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Woman Claims Spirit Airlines Refused to Let Her Board a Flight Home from Miami After She Underwent Cosmetic Surgery
Shataria Banks planned to travel from Miami to Houston on July 23 A woman said she was denied entry onto a Spirit Airlines flight after she underwent a cosmetic surgery procedure, despite having medical clearance to fly from her doctor. Shataria Banks was scheduled to fly home to Houston, Texas, out of Miami International Airport on Wednesday, July 23, after going under the knife in the area several days earlier, according CBS Miami. Banks told the outlet that she presented the airline with a letter from her doctor that stated she was safe to fly after a 'thorough assessment." However, she claimed that airline staff refused to let her board her flight, citing airline "procedure." Banks filmed her encounter with a female employee at what appeared to be a check-in counter. In the video, which she provided to CBS Miami, Banks can be heard asking if the airline states its medical policy anywhere online, so customers can reference it before booking. The airline employee then responds, 'We have a procedure that we have to follow,' adding, 'It's about your safety.' Banks alleged to CBS Miami that airline staff told her that they do not have the official policy in writing anywhere. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. 'I'm not saying that [the airline] can't deny their travelers and they're [not] looking out for their safety, but have something in place, because everybody don't have money to waste for a new flight," Banks said in her interview with the outlet. 'I never want to fly with them, ever, ever," the frustrated flier added. While Banks declined to provide the nature of her surgery to the CBS Miami, a drainage tube and bandages were visible around her abdomen in the filmed video interview. The PEOPLE Puzzler crossword is here! How quickly can you solve it? Play now! In a statement to PEOPLE, a Spirit Airlines spokesperson said passenger safety is the airline's 'top priority.' They added, 'Our records show the agents followed our procedures and consulted with a designated on-call medical professional via our vendor MedLink to verify the guest's fitness to travel.' Medlink provides real-time remote medical assistance to airline staff, both in-flight and on the ground, according to its website. 'The medical professional at MedLink was informed of the guest's documentation and advised that the guest was not fit to travel based on their condition at the time and in the interest of their safety," the representative for the airline said, adding that Banks was "ultimately issued a refund for the flight." Read the original article on People Solve the daily Crossword
News24
12 hours ago
- News24
Should pharmaceutical advertising in SA be better regulated, and why?
Anyone who has travelled to the United States will have been struck by the extent to which medicines, both those requiring a prescription and those that can be bought by consumers without a prescription, are advertised on television. The situation in South Africa is quite different. While there are many advertisements for medicines shown on local television stations, only some are specific about the proprietary (brand) name of the medicine and its indications. Other advertisements focus instead on the indication (the reason for using the medicine), but do not identify it by name. Instead, viewers are urged to approach their pharmacies or medical practitioners. At a different time, an advertisement may be flighted which identifies a medicine, its strength, pack size and perhaps price, but provides no information about what the indication for the medicine is. To what extent does this represent meaningful and justified regulatory control over pharmaceutical marketing? Only two countries with effective medicines regulatory systems allow prescription-only medicines to be advertised directly to the consumer, these being the United States and New Zealand. Other countries, including South Africa, restrict the advertising of prescription-only medicines to the health professionals who can prescribe or dispense them. READ | #InsideTheBox with Dr Andy Gray | Who can prescribe medicines in SA? One of the key justifications for this restriction on the ability of the pharmaceutical industry to market their products is that direct-to-consumer advertising may result in more inappropriate prescribing, when prescribers are under pressure from patients demanding medicines they have seen advertised. Short television advertisements are unlikely to be able to convey a balanced account of the potential benefits and harms of medicines, especially those that are new to the market. South African law contains an interesting variant to regulation in this area. General Regulation 42 issued in terms of the Medicines and Related Substances Act, 1965, allows medicines containing substances in schedules 0 and 1 to be advertised to the public, but requires that those containing substances in schedules 2 to 6 to be advertised 'only for the information of pharmacists, medical practitioners, dentists, veterinarians, practitioners and other authorised prescribers' or 'in a publication which is normally or only made available' to such persons. While Schedule 0 medicines can be bought in any retail outlet, Schedule 1 and 2 medicines can only be obtained from a pharmacy but not self-selected from a shelf. The justification for that particular cut-off is difficult to trace in any policy document. An amendment to the regulation was published for comment in February 2023, but the final regulation has yet to be issued by the minister of health. 'Failure to follow through' The fundamental problem, however, lies in a failure to follow through on the legislation previously passed by Parliament. Section 18C of the current version of the Medicines and Related Substances Act, 1965, contains a prescriptive instruction to the minister. 'The minister shall, after consultation with the relevant industries and other stakeholders, make regulations relating to the marketing of medicines, medical devices or IVDs and such regulations shall also provide for codes of practice for relevant industries,' it states. From 2003 to 2017, the section read: 'The minister shall, after consultation with the pharmaceutical industry and other stakeholders, make regulations relating to the marketing of medicines, and such regulations shall also provide for an enforceable code of practice.' The expansion of the remit to include medical devices and in vitro diagnostics (IVDs) was added by Parliament in 2008 but only took effect in 2017. READ | #InsideTheBox with Dr Andy Gray | Are clinical trial participants in South Africa protected? The wording is peremptory – the minister 'shall' – which leaves no room for delay. While the word 'enforceable' has been removed, the very intent of a regulation is that it should be enforced. That no regulations have been forthcoming in more than 20 years is an extraordinary failure of governance. That failure is compounded by another act of omission. Section 18A of the act states: 'No person shall supply any medicine, medical device or IVD according to a bonus system, rebate system or any other incentive scheme.' The law also enables the minister to 'prescribe acceptable and prohibited acts' in this regard, in consultation with the Pricing Committee. No final regulations have been issued since 2017. The Pricing Committee is established to advise the minister on matters relating to the pricing of medicines, such as the annual maximum increase and the dispensing fees charged by pharmacists and licensed dispensing practitioners. It is already an offence, in terms of Section 29 of the act, for any person to make 'any false or misleading statement in connection with any medicine, scheduled substance, medical device or IVD'. Regulation 42 also states: 'No advertisement for a medicine may contain a statement which deviates from, with or goes beyond the evidence submitted in the application for registration of such medicine with regard to its safety, quality or efficacy where such evidence has been accepted by the authority in respect of such medicine and incorporated into the approved information of such medicine'. While these two provisions may prevent false or misleading advertising, they are limited in their scope. In particular, since no complementary medicines are yet registered by the South African Health Products Regulatory Authority (SAHPRA), none have an approved professional information (previously known as a package insert) or a patient information leaflet. Industry self-regulation The pharmaceutical and medical devices industries have not been idle during this period of government inaction. A non-profit, self-regulatory body, the Marketing Code Authority (MCA), has developed a Code of Marketing Practice, drawing on international guidelines. This code provides for sanctions when rules are broken, following adjudication of a complaint. Fines of up to a maximum of R500 000 can be levied for severe or serious offences, which would, for example, pose 'safety implications for patients'. However, as a self-regulatory body, the MCA cannot require membership by any licensed manufacturer. It means that those manufacturers which are not members of the MCA are not bound by the code and cannot be sanctioned. The MCA therefore advocates that compliance with a code should be a condition to get a licence to operate as a manufacturer. The MCA has also responded to draft regulations on perverse incentives. At a time when deliberate disinformation is being disseminated from many quarters, including from government authorities previously considered to be reliable, a weakened regulatory system cannot simply be allowed to stagger along, in defiance of the express instructions of the legislature. Public safety demands an effective regulatory mechanism to proactively examine pharmaceutical marketing, across all media, the ability to take meaningful action where transgressions are identified and an even playing field for all actors. - Gray is a senior lecturer at the University of KwaZulu-Natal and co-director of the WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice. This is the fourth of a new series of #InsideTheBox columns he is writing for Spotlight. Disclosure: Gray is a member of South Africa's National Essential Medicines List Committee and co-chairs its Expert Review Committee.
News24
a day ago
- News24
Jonathan Roxmouth has brought Broadway home
Jonathan Roxmouth performs eight shows of My Favourite Broadway at Montecasino's Teatro in Johannesburg across two weekends, from 25 July to 3 August. Fresh from acclaimed runs overseas, Jonathan Roxmouth has returned to South African stages with this show that will see the performer reinterpret some of the most recognisable songs in musical theatre. Accompanied by the newly formed 32-piece Egoli Symphonic Orchestra and conducted by long-time collaborator Adam Howard, Roxmouth will perform material drawn from a range of Broadway favourites, from Phantom of the Opera to Les Misérables, and Evita to Funny Girl and Oliver! Discounts are available for early bookings and groups; tickets via Webtickets. WATCH | Gospel meets house music: Mörda and Soweto Gospel Choir collaborate for History of House Known for his theatrical precision and vocal command, Roxmouth will also feature songs from shows he has yet to appear in, adding an element of unpredictability to a show otherwise rooted in the familiar. An outstanding moment promises to be his return to the piano for a special segment with the orchestra. The production comes at a milestone in Roxmouth's career. Later in the year, he will reprise his international role as Billy Flynn in Chicago – The Musical, first at Cape Town's Artscape Theatre (from 27 August), followed by a Johannesburg season at Montecasino's Teatro from 3 October to 9 November. Having mostly worked abroad since 2021, I've missed the South African audience, their warmth and how they receive an artist. It's a unique energy. This concert is a return not just to the stage, but to the songs and people that shaped my early career. Jonathan Roxmouth Howard Events, which is producing the concert, describes the collaboration as both a reunion and a culmination of a decade-long working relationship. 'It's a pleasure to work with Jonathan again. Audiences are in for something extraordinary,' says Howard. JOHANNESBURG: Montecasino's Teatro Friday, 25 July to Sunday, 27 July and Friday, 01 August to Sunday, 03 August 2025 SHOW TIMES: Fridays 19h30; Saturdays 15h00, 19h30; Sundays 14h00 SHOW DURATION: Two hours including intermission TICKET PRICES including VAT R240, R280, R380, R440, R490 BOOKINGS: Tickets on sale at Only valid tickets purchased from Webtickets, the exclusive ticketing agent, may be presented. GROUP BOOKINGS Discount of 20% valid for the top two prices; excludes matinee performances. Discounts for groups of 10 or more. No children under four years permitted
